Ocular structural parameters in children with attention-deficit/hyperactivity disorder: a case-control study of drug-naïve and methylphenidate-treated patients

注意力缺陷/多动障碍儿童的眼部结构参数:一项针对未接受药物治疗和接受哌甲酯治疗患者的病例对照研究

阅读:2

Abstract

PURPOSE: This study aimed to evaluate ocular structural parameters in children with attention-deficit/hyperactivity disorder (ADHD) and to investigate potential differences associated with Methylphenidate Hydrochloride (MPH) treatment. METHODS: In this cross-sectional case-control study, 193 children were included and divided into three groups: Group 1 comprised 56 ADHD patients receiving MPH, Group 2 included 55 drug-naïve ADHD patients, and Group 3 consisted of 82 healthy controls. All participants underwent comprehensive ophthalmologic examinations, including cycloplegic refraction, intraocular pressure (IOP), corneal topography, specular microscopy, and spectral-domain optical coherence tomography (SD-OCT). Retinal nerve fiber layer (RNFL) thickness, macular ganglion cell complex (GCC), and retinal thickness in parafoveal and perifoveal regions were analyzed. RESULTS: No significant differences were observed in refraction, IOP, or corneal parameters among the three groups. OCT measurements showed that superior and inferior RNFL were significantly thinner in MPH-treated ADHD patients compared with controls (p = 0.010 and p < 0.001, respectively). Parafoveal retinal thickness, excluding the nasal quadrant, was increased in drug-naïve ADHD patients (superior p = 0.008, inferior p = 0.015, temporal p = 0.040), whereas perifoveal thickness was reduced in MPH-treated children (superior p = 0.011, inferior p = 0.014, temporal p = 0.004). No significant differences were found in GCC thickness between the groups. No significant correlation was observed between duration of MPH treatment and retinal thickness parameters (all p > 0.05). CONCLUSIONS: Anterior segment parameters were similar across groups, but retinal thickness differed between drug-naïve and MPH-treated ADHD patients, possibly related to disease characteristics or treatment effects, with no clear association with treatment duration. Prospective studies are needed to clarify these effects. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-026-04713-z.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。